Hepatitis B virus persistence after recovery from acute viral hepatitis
- PMID: 8282792
- PMCID: PMC293757
- DOI: 10.1172/JCI116950
Hepatitis B virus persistence after recovery from acute viral hepatitis
Erratum in
-
Hepatitis B virus persistence after recovery from acute viral hepatitis.J Clin Invest. 1994 Aug;94(2):907. doi: 10.1172/jci116950c1. J Clin Invest. 1994. PMID: 8040346 Free PMC article. No abstract available.
Abstract
Contrary to current opinion, the disappearance of hepatitis B surface antigen (HBsAg) from the serum, the development of anti-HBs antibodies, and normalization of liver function may not reflect complete virological recovery from acute hepatitis B virus (HBV) infection. By using the polymerase chain reaction (PCR), in the current study we demonstrate long-term persistence of HBV DNA in the serum and peripheral blood mononuclear cells (PBMC) of four patients for up to 70 mo after complete clinical, biochemical, and serological recovery from acute viral hepatitis. Serum HBV DNA reactivity co-sedimented with HBsAg in sucrose gradients, and it displayed the size and density characteristics of naked core particles and intact HBV virions, presumably contained within circulating immune complexes in these anti-HBs antibody-positive sera. HBV DNA was also present in PBMC in late convalescent samples from all four patients, and HBV RNA was detected in late convalescent phase PBMC in two of these patients. These results suggest that HBV DNA, and possibly HBV virions, can be present in the serum, and that the viral genome can persist in a transcriptionally active form in PBMC for > 5 yr after complete clinical and serological recovery from acute viral hepatitis.
Similar articles
-
Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.J Med Virol. 2004 Feb;72(2):203-14. doi: 10.1002/jmv.10547. J Med Virol. 2004. PMID: 14695661
-
Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.J Clin Virol. 2014 Aug;60(4):347-53. doi: 10.1016/j.jcv.2014.04.021. Epub 2014 May 4. J Clin Virol. 2014. PMID: 24881491
-
Long-term histologic and virologic outcomes of acute self-limited hepatitis B.Hepatology. 2003 May;37(5):1172-9. doi: 10.1053/jhep.2003.50171. Hepatology. 2003. PMID: 12717399
-
Occult hepatitis B virus infection.Transfus Clin Biol. 2004 Feb;11(1):18-25. doi: 10.1016/j.tracli.2003.11.007. Transfus Clin Biol. 2004. PMID: 14980545 Review.
-
Occult hepatitis B virus infection: implications in transfusion.Vox Sang. 2004 Feb;86(2):83-91. doi: 10.1111/j.0042-9007.2004.00406.x. Vox Sang. 2004. PMID: 15023176 Review.
Cited by
-
Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs.Sci Rep. 2016 Nov 7;6:36483. doi: 10.1038/srep36483. Sci Rep. 2016. PMID: 27819342 Free PMC article.
-
Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases.Virol J. 2005 Aug 22;2:70. doi: 10.1186/1743-422X-2-70. Virol J. 2005. PMID: 16115320 Free PMC article. Review.
-
Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.J Virol. 2004 Jun;78(11):5867-74. doi: 10.1128/JVI.78.11.5867-5874.2004. J Virol. 2004. PMID: 15140984 Free PMC article.
-
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.Am J Transplant. 2010 May;10(5):1268-75. doi: 10.1111/j.1600-6143.2010.03070.x. Epub 2010 Mar 19. Am J Transplant. 2010. PMID: 20346065 Free PMC article.
-
Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.J Clin Transl Hepatol. 2015 Sep 28;3(3):211-9. doi: 10.14218/JCTH.2015.00020. Epub 2015 Sep 15. J Clin Transl Hepatol. 2015. PMID: 26623268 Free PMC article. Review.
